These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2972717)

  • 21. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D
    Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
    Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
    J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of activation of rabbit plasminogen by urokinase.
    Sodetz JM; Castellino FJ
    J Biol Chem; 1975 Apr; 250(8):3041-9. PubMed ID: 123529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragments.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Sep; 57(2):387-94. PubMed ID: 126158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifications to the lysine Sepharose method of plasminogen purification which ensure plasmin-free Glu-plasminogen.
    Grant AJ
    Biochem Int; 1990; 20(3):519-27. PubMed ID: 2140680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete amino acid sequence of canine miniplasminogen.
    Schaller J; Straub C; Kämpfer U; Rickli EE
    Protein Seq Data Anal; 1989 Dec; 2(6):445-50. PubMed ID: 2626424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form.
    Ohkura N; Hagihara Y; Yoshimura T; Goto Y; Kato H
    Blood; 1998 Jun; 91(11):4173-9. PubMed ID: 9596664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding of plasminogen fragments to cultured human umbilical vein endothelial cells.
    Wu HL; Wu IS; Fang RY; Hau JS; Wu DH; Chang BI; Lin TM; Shi GY
    Biochem Biophys Res Commun; 1992 Oct; 188(2):703-11. PubMed ID: 1445315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of streptokinase with plasminogen. Isolation and characterization of a streptokinase degradation product.
    Siefring GE; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3913-20. PubMed ID: 932013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kringle domains and plasmin denaturation.
    Shi GY; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1991 Jul; 178(1):360-8. PubMed ID: 1829887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.
    Summaria L; Robbins KC
    J Biol Chem; 1976 Sep; 251(18):5810-13. PubMed ID: 134997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human Glu1-, Lys77-, Val442-, and Val561-plasmin: a comparative study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1990 Aug; 1040(1):134-6. PubMed ID: 2143086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.